IMMX - Latest News
Immix Biopharma, Inc. (IMMX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $542.9M. Beta to the broader market is 0.10.
The article list below shows the most recent IMMX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent IMMX Headlines
All You Need to Know About Immix Biopharma (IMMX) Rating Upgrade to Buy
zacks.com - Jun 24, 2026
Immix Biopharma (IMMX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions
feeds.benzinga.com - Jun 18, 2026
BofA Securities initiates Immix Biopharma with Buy rating, citing NXC-201's potential in AL amyloidosis and peak sales near $963 million.
Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet
zacks.com - Jun 18, 2026
The consensus price target hints at an 113. 6% upside potential for Immix Biopharma (IMMX).
Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High?
zacks.com - May 27, 2026
The consensus price target hints at a 120. 6% upside potential for Immix Biopharma (IMMX).
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
globenewswire.com - May 22, 2026
- Financing includes leading U. S.
How News Affects IMMX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track IMMX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked IMMX news questions
- What is the latest IMMX news headline?
- The most recent IMMX headline (Jun 24, 2026) is "All You Need to Know About Immix Biopharma (IMMX) Rating Upgrade to Buy". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the IMMX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What IMMX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual IMMX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.